Anthony Mancini
Chief Global Commercialization Officer · Revolution Medicines, Inc.
- 2026
- Sep 28, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Anthony Mancini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark A. Goldsmith - $56.99M in RVMD purchases and sales in the last 12 months
- Margaret A. Horn - $25.81M in RVMD purchases and sales in the last 12 months
- Stephen Michael Kelsey - $21.33M in RVMD purchases and sales in the last 12 months
- Jeff Cislini - $15.27M in RVMD purchases and sales in the last 12 months
- Lorence H. Kim - $14.97M in RVMD purchases and sales in the last 12 months
- Jack Anders - $7.13M in RVMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anthony Mancini?
Anthony Mancini is a corporate insider, tracked as Chief Global Commercialization Officer of Revolution Medicines, Inc. (RVMD). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anthony Mancini submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Anthony Mancini been buying or selling stock?
Recorded transactions: 0 open-market purchases and 22 open-market sales ($9.79M) across all tracked filings.
